Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation.

Coester C, Nayyar P, Samuel J.

Eur J Pharm Biopharm. 2006 Apr;62(3):306-14. Epub 2005 Nov 28.

PMID:
16316749
2.

Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.

Ofokansi K, Winter G, Fricker G, Coester C.

Eur J Pharm Biopharm. 2010 Sep;76(1):1-9. doi: 10.1016/j.ejpb.2010.04.008. Epub 2010 Apr 24.

PMID:
20420904
3.
4.

Novel glycidyl methacrylated dextran/gelatin nanoparticles loaded with basic fibroblast growth factor: formulation and characteristics.

Gu C, Zheng R, Yang Z, Wen A, Wu H, Zhang H, Yi D.

Drug Dev Ind Pharm. 2009 Dec;35(12):1419-29. doi: 10.3109/03639040902988558.

PMID:
19929201
5.

Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation.

Seydoux E, Rothen-Rutishauser B, Nita IM, Balog S, Gazdhar A, Stumbles PA, Petri-Fink A, Blank F, von Garnier C.

Int J Nanomedicine. 2014 Aug 13;9:3885-902. doi: 10.2147/IJN.S64353. eCollection 2014.

6.

Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts.

Gupta AK, Gupta M, Yarwood SJ, Curtis AS.

J Control Release. 2004 Mar 5;95(2):197-207.

PMID:
14980768
7.

Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.

Diwan M, Elamanchili P, Lane H, Gainer A, Samuel J.

J Drug Target. 2003;11(8-10):495-507.

PMID:
15203918
8.

Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery.

Chen FM, Ma ZW, Dong GY, Wu ZF.

Acta Pharmacol Sin. 2009 Apr;30(4):485-93. doi: 10.1038/aps.2009.15. Epub 2009 Mar 23.

9.
10.

Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy.

Cruz LJ, Rueda F, Cordobilla B, Simón L, Hosta L, Albericio F, Domingo JC.

Mol Pharm. 2011 Feb 7;8(1):104-16. doi: 10.1021/mp100178k. Epub 2010 Dec 20.

PMID:
21121669
11.

Functional characterization of biodegradable nanoparticles as antigen delivery system.

Petrizzo A, Conte C, Tagliamonte M, Napolitano M, Bifulco K, Carriero V, De Stradis A, Tornesello ML, Buonaguro FM, Quaglia F, Buonaguro L.

J Exp Clin Cancer Res. 2015 Oct 6;34:114. doi: 10.1186/s13046-015-0231-9.

12.
13.

Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.

Dinauer N, Balthasar S, Weber C, Kreuter J, Langer K, von Briesen H.

Biomaterials. 2005 Oct;26(29):5898-906. Epub 2005 Apr 15.

PMID:
15949555
15.

Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells.

Azarmi S, Huang Y, Chen H, McQuarrie S, Abrams D, Roa W, Finlay WH, Miller GG, Löbenberg R.

J Pharm Pharm Sci. 2006;9(1):124-32.

16.

Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.

Slütter B, Plapied L, Fievez V, Sande MA, des Rieux A, Schneider YJ, Van Riet E, Jiskoot W, Préat V.

J Control Release. 2009 Sep 1;138(2):113-21. doi: 10.1016/j.jconrel.2009.05.011. Epub 2009 May 13.

PMID:
19445980
17.

Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition.

Foged C, Arigita C, Sundblad A, Jiskoot W, Storm G, Frokjaer S.

Vaccine. 2004 May 7;22(15-16):1903-13.

PMID:
15121302
18.

Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases.

Brzoska M, Langer K, Coester C, Loitsch S, Wagner TO, Mallinckrodt Cv.

Biochem Biophys Res Commun. 2004 May 28;318(2):562-70.

PMID:
15120637
19.

Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines.

Chua BY, Al Kobaisi M, Zeng W, Mainwaring D, Jackson DC.

Mol Pharm. 2012 Jan 1;9(1):81-90. doi: 10.1021/mp200264m. Epub 2011 Dec 16.

PMID:
22149016
20.

"Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.

Elamanchili P, Lutsiak CM, Hamdy S, Diwan M, Samuel J.

J Immunother. 2007 May-Jun;30(4):378-95.

PMID:
17457213

Supplemental Content

Support Center